Max Nisen is a Bloomberg Gadfly columnist covering biotech, pharma and health care. He previously wrote about management and corporate strategy for Quartz and Business Insider.

Good morning! This is Fly Charts, the daily charts-only newsletter from Gadfly; sign up here. From Astra's deal prospects to the Southeast gas crunch, here are four charts that tell you what you need to know in business today.

Be Impressed
There are very few companies in the world that can make Google look like a valuation laggard. But Tencent manages it handily.
Source: Bloomberg
Note: Share gains are adjusted for stock splits.
The Upside Downstream
Hurricane Harvey's impact is about logistics rather than supply. But the Southeast can weather the gas impact.
Source: Bloomberg
Note: As of Thursday morning, August 31, 2017. Changes in current Nymex futures price.
Spot the Outlier
Vivendi's overly generous offer for Havas looks even worse as the rest of the advertising business continues to trade lower.
Source: Bloomberg
The Moment Has Passed
After disappointing cancer drug data, AstraZeneca looks more like a target than the acquirer it's rumored to be.
Source: Bloomberg

And don't miss Tim Culpan on why Toshiba should stand by its chip unit: "If Toshiba sold the memory-chip unit for $18 billion and provisioned for its nuclear liabilities and negative equity, it would be left with $7.6 billion. There would be other outstanding debts, but what the company wouldn't have is the unit that brings in about one-third of revenue and operating income. It would also be left with a bucket of cash and nowhere to spend it."

This column does not necessarily reflect the opinion of Bloomberg LP and its owners.

To contact the author of this story:
Max Nisen in New York at

To contact the editor responsible for this story:
Mark Gongloff at